Filtered By:
Specialty: International Medicine & Public Health

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 794 results found since Jan 2013.

TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide appeared first on Inter Press Service.
Source: IPS Inter Press Service - Health - March 25, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Africa Headlines Health Source Type: news

Newer anti-HIV drugs safest, most effective during pregnancy
(NIH/National Institute of Allergy and Infectious Diseases) The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available during pregnancy, researchers announced today. Their findings come from a multinational study of more than 640 pregnant women with HIV across four continents. The current study compared three antiretroviral drug regimens and found that regimens containing dolutegravir (DTG) were more effective in suppressing HIV than a commonly used regimen containing efavirenz (EFV).
Source: EurekAlert! - Medicine and Health - March 11, 2020 Category: International Medicine & Public Health Source Type: news

NIH study finds lower concentration of PrEP drug in pregnant young women
(NIH/National Institute of Allergy and Infectious Diseases) Among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenofovir were more than 30% lower in those who were pregnant than in those who had recently given birth. All 40 study participants took PrEP under direct observation, confirming their near-perfect adherence.
Source: EurekAlert! - Medicine and Health - March 9, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 a reminder of the challenge of emerging infectious diseases
(NIH/National Institute of Allergy and Infectious Diseases) The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC). Their commentary appears in The New England Journal of Medicine.
Source: EurekAlert! - Medicine and Health - February 28, 2020 Category: International Medicine & Public Health Source Type: news

Electron microscopy allows scientists to understand the molecular trigger of allergic reactions
(Aarhus University) For the first time, researchers from the Department of Engineering and the Department of Molecular Biology and Genetics at Aarhus University have described the structure of an IgE antibody responsible for allergic reactions. Moreover, the researchers could also describe the mode of action of an anti-allergy therapeutic antibody. These results represent a breakthrough in our understanding of antibodies and could have a major impact on development of new medicine in years to come.
Source: EurekAlert! - Medicine and Health - February 24, 2020 Category: International Medicine & Public Health Source Type: news

Lung function in the German National Cohort: methods and initial results.
DISCUSSION: The results of spirometry and the FeNO measurements are in the expected range with regard to their distributions and correlates. The GNC provides a valuable basis for future investigations of respiratory health and its determinants as well as research into the prevention of respiratory diseases in Germany. PMID: 32078705 [PubMed - as supplied by publisher]
Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz - February 19, 2020 Category: International Medicine & Public Health Authors: Karrasch S, Peters A, Meisinger C, Ferland M, Jaeschke L, Pischon T, Fricke J, Keil T, Gastell S, Schulze M, Brandes M, Günther K, Kuß O, Schikowski T, Emmel C, Jöckel KH, Michels KB, Franzke CW, Langer S, Mikolajczyk R, Jagodzinski A, Becher H, Castel Tags: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Source Type: research

Are We Meeting Their Needs? Well-child, Dental, and Mental Health Care for Youth in Juvenile Correctional Facilities in Minnesota.
Abstract Compared with the general population, justice-involved youth have substantially higher rates of several health conditions. Less is known about their use of health services to address these conditions. Using data from a statewide survey of 217 youth in juvenile correctional facilities and 164,832 youth in public schools, we examined selfreported health (health overall, weight status, disability, asthma, allergy, mental health) and receipt of care. Justice-involved youth reported a high number of physical health concerns; however, physical health conditions were not related to receipt of care. Youth who rep...
Source: Journal of Health Care for the Poor and Underserved - February 12, 2020 Category: International Medicine & Public Health Authors: Brown C, Davis L, Shlafer RJ Tags: J Health Care Poor Underserved Source Type: research

First human trial of monoclonal antibody to prevent malaria opens
(NIH/National Institute of Allergy and Infectious Diseases) A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Source: EurekAlert! - Medicine and Health - January 27, 2020 Category: International Medicine & Public Health Source Type: news

Family history and cord blood eosinophil count as predictors for atopic manifestations.
CONCLUSIONS: A positive medical history, especially of mothers and cEo, seem to be predictive in screening for the onset of allergic diseases. PMID: 31951684 [PubMed - in process]
Source: Central European Journal of Public Health - January 19, 2020 Category: International Medicine & Public Health Tags: Cent Eur J Public Health Source Type: research

A study on respiratory morbidities and pulmonary functions among traffic policemen in Bengaluru city
Conclusions: There was increased burden of respiratory problems and lower lung volumes and flows among traffic policemen.
Source: Indian Journal of Community Medicine - January 13, 2020 Category: International Medicine & Public Health Authors: Giriyanna Gowda R Thenambigai Source Type: research

Mysterious Cause of Respiratory Failure and Multilobar Atelectasis in a 17-Month-Old Male.
Authors: Davis GW, Lockett CJ, Charny G Abstract A 17-month-old male presented to a community hospital emergency department in respiratory distress suggestive of reactive airway exacerbation or pneumonia. He rapidly deteriorated into fulminant respiratory failure with multilobar atelectasis. He was managed with continuous albuterol, intravenous antibiotics, corticosteroids, intubation, and vasopressors. He was then transported to a tertiary Children's Hospital. The patient was extubated 20 hours after presentation and again developed respiratory failure while in the pediatric intensive care unit. During preparatio...
Source: Military Medicine - January 11, 2020 Category: International Medicine & Public Health Tags: Mil Med Source Type: research

New MS treatment trial compares stem cell transplantation to best available drugs
(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will compare the safety, efficacy and cost-effectiveness of the two therapeutic approaches.
Source: EurekAlert! - Medicine and Health - January 7, 2020 Category: International Medicine & Public Health Source Type: news

Infectious Diseases Clinical Research Consortium Awards announced
(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced the establishment of the Infectious Diseases Clinical Research Consortium, a clinical trials network that will encompass the Institute's long-standing Vaccine and Treatment Evaluation Units (VTEUs) and create a new consortium leadership group. NIAID intends to provide approximately $29 million per year for seven years for the VTEU program and its companion leadership group.
Source: EurekAlert! - Medicine and Health - December 19, 2019 Category: International Medicine & Public Health Source Type: news

Reducing mouse allergens may improve lung growth in asthmatic children
(University of Texas at Austin) Lowering exposure to allergens from mice may lead to improved lung growth for children with asthma living in low-income neighborhoods, helping them avoid lung ailments and possibly live longer, according to newly published research in The Journal of Allergy and Clinical Immunology.
Source: EurekAlert! - Social and Behavioral Science - December 19, 2019 Category: International Medicine & Public Health Source Type: news

Forty percent of people with peanut allergies can eat tree nuts but choose not to
(American College of Allergy, Asthma, and Immunology) New study showed that nearly 90% of people with peanut allergy could potentially tolerate almonds, but 33% of that group preferred strict avoidance due to fear of an allergic reaction.
Source: EurekAlert! - Medicine and Health - December 18, 2019 Category: International Medicine & Public Health Source Type: news